Rhinitis News and Research

RSS
Rhinitis, commonly known as a runny nose, is the medical term describing irritation and inflammation of some internal areas of the nose. The primary symptom of rhinitis is nasal dripping. It is caused by chronic or acute inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants.
Soligenix obtains additional funding from NIAID to advance development of OrbeShield for GI ARS treatment

Soligenix obtains additional funding from NIAID to advance development of OrbeShield for GI ARS treatment

SUNY Downstate Medical Center researchers identify ALPIM syndrome as new spectrum disorder

SUNY Downstate Medical Center researchers identify ALPIM syndrome as new spectrum disorder

Danish nasal filter prevents pollen inhalation, reduces symptoms of hay fever

Danish nasal filter prevents pollen inhalation, reduces symptoms of hay fever

Nuvo obtains Health Canada approval to conduct WF10 Phase 2 trial for treatment of allergic rhinitis

Nuvo obtains Health Canada approval to conduct WF10 Phase 2 trial for treatment of allergic rhinitis

Nuvo Research provides details of new WF10 Phase 2 clinical trial for treatment of allergic rhinitis

Nuvo Research provides details of new WF10 Phase 2 clinical trial for treatment of allergic rhinitis

Egalet announces plans to commercialize SPRIX Nasal Spray and OXAYDO tablets

Egalet announces plans to commercialize SPRIX Nasal Spray and OXAYDO tablets

Egalet announces net revenues of $1.9 million for 2014

Egalet announces net revenues of $1.9 million for 2014

New article shows how marijuana can act as an allergen

New article shows how marijuana can act as an allergen

Shire announces acquisition of Meritage Pharma

Shire announces acquisition of Meritage Pharma

Experts recommend sublingual immunotherapy for treatment of allergic rhinitis

Experts recommend sublingual immunotherapy for treatment of allergic rhinitis

Nuvo Research announces topline results from WF10 Phase 2 allergic rhinitis clinical trial

Nuvo Research announces topline results from WF10 Phase 2 allergic rhinitis clinical trial

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Leading microbiologist warns of killer fungi’s increasing threat

Leading microbiologist warns of killer fungi’s increasing threat

Oral budesonide suspension offers hope for pediatric patients with EoE

Oral budesonide suspension offers hope for pediatric patients with EoE

Nuvo Research completes WF10 Phase 2 trial in patients with refractory allergic rhinitis

Nuvo Research completes WF10 Phase 2 trial in patients with refractory allergic rhinitis

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Exposure to indoor air pollution affects children's lungs

Exposure to indoor air pollution affects children's lungs

Avanir Pharmaceuticals to publish AVP-825 phase III study results in the journal 'Headache'

Avanir Pharmaceuticals to publish AVP-825 phase III study results in the journal 'Headache'

Children infected with enterovirus more likely to have type 1 diabetes

Children infected with enterovirus more likely to have type 1 diabetes

Researchers working to develop new drugs for treating chronic inflammatory diseases

Researchers working to develop new drugs for treating chronic inflammatory diseases